StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Advertising expense (% of consolidated revenue) by Year

Advertising expense (% of consolidated revenue) (%)

Eli Lilly Advertising expense (% of consolidated revenue): 5.0% in FY2025, unchanged from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
5.0%
Period ended Dec 31, 2025
Change on a year earlier
0.0 pts
5.0% in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-12) ↗

Reported in Form 10-K Note 1 Summary of Significant Accounting Policies.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAdvertising expense (% of consolidated revenue) (%)Year on yearSource
FY2025Dec 31, 20255.0%0.0 ptsForm 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 20245.0%0.0 ptsForm 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 20235.0%0.0 ptsForm 10-K (filed 2026-02-12) ↗
FY2022Dec 31, 20225.0%0.0 ptsForm 10-K (filed 2025-02-19) ↗
FY2021Dec 31, 20215.0%0.0 ptsForm 10-K (filed 2024-02-21) ↗
FY2020Dec 31, 20205.0%0.0 ptsForm 10-K (filed 2023-02-22) ↗
FY2019Dec 31, 20195.0%0.0 ptsForm 10-K (filed 2022-02-23) ↗
FY2018Dec 31, 20185.0%0.0 ptsForm 10-K (filed 2021-02-17) ↗
FY2017Dec 31, 20175.0%–Form 10-K (filed 2020-02-19) ↗

Cite this data

StockData. (2026). Eli Lilly Advertising expense (% of consolidated revenue) (%), annual FY2017–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/adv-pct-revenue

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.